Methyl 2-chloro-4-fluoronicotinate

Catalog No. :
ACLPRX461
CAS No. :
1805523-13-0
Molecular Formula :
C7H5ClFNO2
Molecular Weight :
189.57

IUPAC Name:methyl 2-chloro-4-fluoronicotinate

Methyl 2-chloro-4-fluoronicotinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$97.00Login to see priceIn stockIn stock
5g97%$382.00Login to see priceIn stockIn stock
25g97%$1528.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-chloro-4-fluoronicotinate
IUPAC Namemethyl 2-chloro-4-fluoronicotinate
MDL No.MFCD28752447
Molecular FormulaC7H5ClFNO2
Molecular Weight189.57
SMILESO=C(C1=C(F)C=CN=C1Cl)OC
InChI KeyIBKKZHVCBRURRQ-UHFFFAOYSA-N
Synonym3-Pyridinecarboxylic acid, 2-chloro-4-fluoro-, methyl ester;METHYL 2-CHLORO-4-FLUOROPYRIDINE-3-CARBOXYLATE;methyl 2-chloro-4-fluoronicotinate;2-methyl-1,3-thiazole-6-carboxylic acid;methyl 2-chloro-4-fluoropyridine-3-carboxylate - [M83875]
CAS No.1805523-13-0
PubChem CID124251635

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACLPRX461 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLPRX461 route product structure diagram
    ACLPRX4611805523-13-0 In Stock
Inquiry

2. ACLPRX461 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACUDSM850 route compound structure diagram
    ACUDSM850929022-76-4 In Stock
  4. Then
  5. ACLPRX461 route product structure diagram
    ACLPRX4611805523-13-0 In Stock
Inquiry

Comments (0)